The contentious battle between LabMD and the Federal Trade Commission over the adequacy of the medical testing firm’s data security practices—the first such case to go to administrative trial—is set for closing arguments on September 14, and the acrimony continues.
LabMD’s scorched-earth litigation strategy most recently has included a motion—its second
This content can only be accessed by FTC:WATCH subscribers.
FTC:WATCH is published 22 times a year - twice a month except in August when Northern Hemisphere governments leave town.FTC:WATCH is delivered in the following formats:
- online at ftcwatch.com via IP address recognition for enterprise wide distribution
- online at ftcwatch.com via secure username and password
- PDF version delivered by email
If you are an FTC:WATCH subscriber, please login to access this content: